FindTrial
Sign In

Myocardial protection in pediatric patients undergoing liver transplantation

Myocardial protective strategies of pediatric liver transplantation with biliary atresia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015778
Enrollment
Unknown
Registered
2018-04-20
Start date
2018-04-20
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital biliary atresia

Interventions

Propofol:Propofol compound anesthesia
Sev:Sev compound anesthesia

Sponsors

Tianjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: (1) the classification of anaesthesia (ASA grade) I to III; (2) Cardiac function grade I to II;

Exclusion criteria

Exclusion criteria: (1) Repeate liver transplantation; (2) patients complicated with heart, lung and kidney failure; (3) Complicated with congenital heart disease.

Design outcomes

Primary

MeasureTime frame
cTNI;CK-MB;ICU stay time;Hospital stay time;30-day mortality rate;—

Countries

China

Contacts

Public ContactYu Wenli

Tianjin First Center Hospital

yzxyuwenli@163.com+86 13920098326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026